Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico

As clinicians and scientists gather more data on the clinical trajectory of COVID-19 and the biology of its causative agent, the SARS-CoV-2 virus, novel strategies are needed to integrate these data to inform new therapies. A recent study by Howell et al. introduces a network model of viral-host int...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, James A., Raza, Marium M., Venkatesh, Kaushik P., Kvedar, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033809/
https://www.ncbi.nlm.nih.gov/pubmed/35459899
http://dx.doi.org/10.1038/s41746-022-00599-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033809/
https://www.ncbi.nlm.nih.gov/pubmed/35459899
http://dx.doi.org/10.1038/s41746-022-00599-5

Ejemplares similares